LOUIS JEFFERSON
(Global Clinical Trial Management)
Education/ Certification/ Training
The Medical University of Ohio, Toledo, Ohio
Completed Two Academic Years 2004-2006
University of Connecticut, Hartford, CT
Medical Post-Baccalaureate Program, May 2002
University of Pittsburgh, Pittsburgh, PA
Master of Public Health, August 1993
Vice President's Scholarship/GSPH
Kent State University, Kent, Ohio
Master of Health Education, December 1991
Graduate Assistant of the Year, Teaching Fellow
Kent State University, Kent, Ohio
Bachelor of Science in Human Physiology, December 1988
Athletic Scholarship/Varsity Football Captain
Experience
EPM Scientific Sept 2021 - Present
Clinical Study Manager Phase I-II Oncology Clinical Trials
Operational Management of Phase I-II Immunological/Oncology Trials
Study start-up activities: Contract and Budget Negotiations with Oncology Collaborative Groups and Clinical Sites, Vendor selection/management, Regulatory Document Management, manage and facilitate protocol, ICF, eCRF, eCRF Guideline development and distribution.
Draft all study plans and facilitate dissemination
Study Maintenance activities: Site and subject recruitment management, management of interim analyses, review data management line listings, review monitoring visit reports, facilitate cross functional operations meetings.
Study Completion Activities – Manage Database Locks, Manage Trial Master File reconciliation, manage necessary site close out activities according to GCP/ICH guidelines.
USTechSolutions, Inc. May 2020- Sept 2021
Clinical Research Study Leader - Early Stage Clinical Trials
Operational Management of Phase I-II and Healthy Volunteer Neuroscience Trials
Study start -up activities: Contract and Budget Negotiations with Neurodegenerative Disorder Collaborative Groups and Clinical Sites, Vendor selection/management, Recruitment, Regulatory Document Management, manage and facilitate protocol development and distribution
Study Maintenance activities: Site and subject recruitment management, management of interim analyses, review data management line listings, review monitoring visit reports, facilitate cross-functional operations meetings.
AstraZeneca Pharmaceutical, Inc. (Contract) Sept 2017- Apr 2020
Clinical Study Manager Phase I-III Oncology Clinical Trials
Operational Management of Phase I-III Immunological/Oncology Trials
Study start-up activities: Contract and Budget Negotiations with Oncology Collaborative Groups and Clinical Sites, Vendor selection/management, Regulatory Document Management, manage and facilitate protocol development and distribution
Study Maintenance activities: Site and subject recruitment management, management of interim analyses, review data management line listings, review monitoring visit reports, facilitate cross functional operations meetings.
Study Completion Activities – Manage Database Locks, Manage Trial Master File reconciliation, manage necessary site close out activities according to GCP/ICH guidelines.
Therapeutic areas consist of oncology.
Provide clinical trial management for the potential partner Protagonist, Inc.
oTherapeutic Areas of Gastrointestinal and Hematology
oStudy start-up activities: Contract and Budget Negotiations with Oncology Collaborative Groups and Clinical Sites, Vendor selection/management, Regulatory Document Management, manage and facilitate protocol development and distribution
oProvide International Clinical Management Training in India
inVentiv Health., (Homebased - Contract) Dec 2015 – Aug 2017
Clinical Study Manager Phase I-III Immunological/Oncology Clinical Trials
Operational Management of Phase I-III Immunological/Oncology Trials
Study start-up activities: Contract and Budget Negotiations with Oncology Collaborative Groups and Clinical Sites, Vendor selection/management, Regulatory Document Management, manage and facilitate protocol development and distribution
Study Maintenance activities: Site and subject recruitment management, management of interim analyses, review data management line listings, review monitoring visit reports, facilitate cross functional operations meetings.
Study Completion Activities – Manage Database Locks, Manage Trial Master File reconciliation, manage necessary site close out activities according to GCP/ICH guidelines.
Therapeutic areas consist of oncology, CNS, and hematology.
Aerotek/Advance VACO Consultant - Genentech Inc., South San Francisco, CA May 2014 –Dec 2015
Clinical Study Manager Phase I-III Oncology Clinical Trials
Operational Management of Phase I-III Solid Tumor Trials
Study start-up activities: Manage Database Development with Data Managers, Contract and Budget Negotiations with Oncology Collaborative Groups and Clinical Sites, Vendor selection/management, Regulatory Document Management, manage and facilitate protocol development and distribution
Study Maintenance activities: Site and subject recruitment management, management of interim analyses, review data management line listings, review monitoring visit reports, facilitate cross functional operations meetings.
Study Completion Activities – Manage Database Locks, Manage Trial Master File reconciliation, manage necessary site close out activities according to GCP/ICH guidelines.
Therapeutic areas consist of oncology, CNS, rare diseases and hematology.
Expert Clinical Study Manager for multiple Phase I-III Oncology Clinical Trials.
Monitor Unblinded Drug Administration Records, AE and ECG Data
Manage Unblinded SAE query resolution, TMF management, and data management.
Manage Global Clinical Trials
Therapeutic areas consist of oncology
Global Management for Quintiles, Genentech and Novartis
Manage SAE query resolution, TMF management, and data management.
Manage Database Development with contacted/sponsor Data Managers.
Manage Patient Recruitment Strategies
Supervise Site Management: manage the process of identifying, selecting, initiating and closing-out investigational sites for clinical studies and ensuring adherence to applicable regulations and principles of ICH-GCP
Manage Local Clinical Trial Managers
Targacept, Winston Salem, NC April 2013- May 2014
Sr. Clinical Study Manager for Phase II Alzheimer’s Trials and Gastrointestinal Trials
Phase I-II Protocol writing and key member on the Study Design Team for Phase I and II protocol development
Manage Database Development with contracted Data Managers
Supervise Site Management: manage the process of identifying, selecting, initiating and closing-out investigational sites for clinical studies and ensuring adherence to applicable regulations and principles of ICH-GCP
Manage Patient Recruitment Strategies
Supervise conduct of Alzheimer’s Trials and Gastrointestinal protocols, including:
Vendor management, Operational management of CROs in various international locations, manage SAE query resolution, records management, fiscal management, and data management
Drug class consist of Neuro-Nicotinics
Manage Quality Assurance of Phase I protocols
J& J/Janssen Pharmaceutical Companies, L.A., CA Sept-2010 - Jun 2013
Global Study Manager for Phase II Oncology Clinical Trials
Supervise conduct of Advance Prostate Cancer protocols, including:
Vendor management, Operational management through Local Study Managers at various country locations, manage SAE query resolution, records management, fiscal management, and data management.
Manage Patient Recruitment Strategies
Manage Database Development, Maintenance and Database locks with Data Managers. Including development of Data Management Plans and implementation
Manage Local Clinical Trial Managers
Therapeutic areas consist of oncology and endocrinology.
Manage Quality Assurance of Phase I protocols.
Phase II Regenerative Medicine Clinical Trials
Manage and Monitor Clinical Sites
Operational Management of rhGDF-5 Clinical Trials
Supervise the conduct of clinical trials on the clinical site level for multiple national sites
Manage Patient Recruitment Strategies
Manage site regulatory compliance
Manage Drug Accountability
Contract and Budget management for clinical site and vendors
Prometheus Laboratories, Inc., San Diego, CA Sept 2009 – Sept-2010
Sr. Manager Phase I-II Oncology Clinical Trials
Site Monitoring including the following: identifying, selecting, initiating and closing-out investigational sites for clinical studies ensuring adherence to applicable regulations and principles of ICH-GCP
Manage Database Development with contracted Data Managers
Operational Management of Phase I-II Refractory Solid Tumor Trials
Study start-up activities: Protocol writing, CRF development, Investigator’s Brochure Summaries, Regulatory Document Management, CRO selection/management, Budget negotiations and Investigator’s meeting management.
Study Maintenance activities: site and subject recruitment management, management of interim analysis, review data management line listings, review monitoring visit reports
Manage Patient Recruitment Strategies
Study Management of Oncology Investigator Sponsored Studies Program.
Manage operations of multiple concepts submitted by national and international KOLs
Lead Cross Functional Review Meetings
Performed multiple protocol reviews for multiple therapeutic regimens for multiple tumor types
Budget negotiations
Review Data Management Line Listings for Safety
Study start-up activities: Protocol writing, CRF development, Investigator’s Brochure Summaries, Regulatory Document Management, CRO selection/management, and Investigator’s meeting management.
Close out activities and management of Clinical Study Report
Manage Cross Functional Teams to align their goals with Clinical Study Timelines
Line Management and indirect management of CRAs and CPAs
Therapeutic areas consist of oncology, CNS, and hematology.
Amgen, Inc., Thousand Oaks, CA May 2006 – August 2009
Global Clinical Research Manager Phase I-II Oncology Clinical Trials
Operational Management of Phase I-II Refractory Solid Tumor Trials
Study start-up activities: Protocol writing, CRF development, Investigator’s Brochure Summaries, Regulatory Document Management, CRO selection/management, Budget negotiations and Investigator’s meeting management.
Study Maintenance activities: site and subject recruitment management, management of interim analysis, review data management line listings, review monitoring visit reports
Clinical Study Manager Consultant Phase II-IIIB Clinical Trials
Study Management of Oncology Investigator Sponsored Studies Program.
Manage operations of multiple concepts submitted by national and international KOLs
Lead Cross Functional Review Meetings
Performed multiple protocol reviews for multiple therapeutic regimens for multiple tumor types
Budget negotiations
Review Data Management Line Listings for Safety
Study start-up activities: Protocol writing, CRF development, Investigator’s Brochure Summaries, Regulatory Document Management, CRO selection/management, and Investigator’s meeting management.
Close out activities and management of Clinical Study Report
Manage Cross Functional Teams to align their goals with Clinical Study Timelines
Line Management and indirect management of CRAs and CPAs
Therapeutic areas consist of oncology, CNS, and hematology.
Pfizer, Inc., Feb. 1999-Aug. 2005
NYC, NY and Groton, CT
Clinical Study Manager
Study Manager for Worldwide Phase III Anti-fungal Clinical Trial.
Supervise conduct of Anti-fungal protocols, including:
Preparation of SAE Reports to update AEM database, manage SAE query resolution, CRO and Contract CRA management, fiscal management, and data management.
Site Monitoring including the following: identifying, selecting, initiating and closing-out investigational sites for clinical studies ensuring adherence to applicable regulations and principles of ICH-GCP
Study budget management.
Therapeutic areas consist of infectious disease, immune/allergy, oncology, and ophthalmology.
Manage Quality Assurance of Phase I protocols.
Bayer, Inc., June 1997-Feb. 1999
West Haven, CT
Medical Research Associate
Supervise the conduct of 10 clinical sites for Anti-Infective Protocols.
Therapeutic areas consist of Upper Respiratory and Gastrointestinal.
Responsible for site evaluation, initiation, Close-out visits, Data listings, Monitoring and reviewing Audit Reports.
Project Team leader/CRO Management
Responsibilities include: Preparing progress reports for Bayer Product Development Team; Primary contact for CRO management and field staff; Oversee investigator recruitment efforts; Prepare narratives for medical research reports.
AMGEN, Inc., June 1995-June 1997
Thousand Oaks, CA
Clinical Research Associate
Supervised the conduct of clinical trials for Phase III Biotechnology protocols.
Responsible for site evaluation, initiation, Close-out visits.
Data listings, Monitoring, Planning and conducting Investigator's meetings and Audit Reports
Therapeutic areas include Nephrology, Cardiovascular disease and infectious disease.
Skills
Assessment and Evaluation
Data Collection and Analysis utilizing Remote Data Entry(RAVE, DataLabs, Coordinator Online and SiteBase Management
Interactive Voice Response Systems (IVRS)
Data Collection and Analysis utilizing statistical software packages (SAS, SPSS, BMDP)
Clinical Trial Management System (CTMS)
Quantum Business Process
Human Physiology-Pulmonary functioning test, Stress test, ECG, Phase I-III Cardiac rehabilitation, anthropometric measurement, daily vital signs.
Health Education and Research
Coordinated Health Outcomes Research for Clinical Trials
Research Coordinator-Analyzed, collected data, screened and enrolled study participants for The University of Pittsburgh's Dept. of Epidemiology and Social Work for clinical study of cardiovascular disease to determine the risk factors associated with individuals 65 and older.
Development Specialist- Developed, procured grants and implemented health education programs for public schools, universities, hospitals and community-based settings